[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Edgewise Therapeutics, Inc. Common Stock (EWTX)
Edgewise Therapeutics sees positive analyst ratings and strong social engagement due to positive data on Sevasemten. Despite market volatility, the stock shows promise with upcoming catalysts and positive sentiment from the community.
About Edgewise Therapeutics, Inc. Common Stock
Edgewise Therapeutics, Inc. Common Stock (EWTX) is a healthcare stock focused on muscle-based therapies.
Edgewise Therapeutics, Inc. Common Stock uses the ticker $EWTX for trading. Listed in the Stocks and category within the Healthcare sectors.
Insights #
- Edgewise Therapeutics, Inc. Common Stock (EWTX) trading volume is up XXXXX% from the previous month.
- Edgewise Therapeutics, Inc. Common Stock (EWTX) social dominance is up XXX% from the previous month.
- Edgewise Therapeutics, Inc. Common Stock (EWTX) sentiment is up XXX% from the previous week.
Price: $XXXXX #
Price 24-Hour Time-Series Raw Data
The current price of $XXXXX is likely influenced by positive data presentations, analyst ratings, and inclusion in biotech watchlists, despite market volatility. The recent price drop from its 1-year high suggests some investor caution.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| -XXXX% | -XXXX% | XXXX% |
1-Year High: $XXXXX on 2024-11-06
1-Year Low: $XXXXX on 2025-04-12
AltRank: XXX #
AltRank 24-Hour Time-Series Raw Data
Edgewise Therapeutics, Inc. Common Stock (EWTX) is currently AltRank #184 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXXXX +321
1 Month: XXX -XXXXX
6 Months: XXX -XX
1 Year: XXX -XXX
1-Year High: XXXXX on 2025-09-15
1-Year Low: XX on 2024-12-12
Galaxy Score: XXXXX #
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX -X
1 Month: XX +1
6 Months: XX -XX
1 Year: XX -XX
1-Year High: XX on 2024-12-03
1-Year Low: XX on 2024-11-15
Engagements: XXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXXX
1 Week: XXXXX -XX%
1 Month: XXXXXX -XX%
6 Months: XXXXXXXXX -XX%
1 Year: XXXXXXXXX +30%
1-Year High: XXXXXXX on 2024-12-16
1-Year Low: XX on 2025-09-14
| Social Network | X |
|---|---|
| Engagements | XXX |
Mentions: XX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XX -XX%
6 Months: XXXXX -XX%
1 Year: XXXXX +64%
1-Year High: XXX on 2024-12-04
1-Year Low: X on 2025-09-15
| Social Network | X |
|---|---|
| Mentions | XX |
Creators: XX #
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Edgewise Therapeutics, Inc. Common Stock (EWTX) in the last XX hours which is no change from in the previous XX hours
Daily Average: XX
1 Month: XX -XX%
6 Months: XXXXX +35%
1 Year: XXXXX +161%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-15
The most influential creators that mention Edgewise Therapeutics, Inc. Common Stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | X | XXXXXX | X | XXX |
| @Quantumup1 | X | XXXXX | X | XX |
Sentiment: XXX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
1 Week: XXX% +50%
1 Month: XXX% no change
6 Months: XXX% +26%
1 Year: XXX% +17%
1-Year High: XXX% on 2025-01-29
1-Year Low: XX% on 2025-03-21
Most Supportive Themes
- Positive Data and Presentations: (45%) Edgewise Therapeutics is presenting positive data on Sevasemten for Becker and Duchenne Muscular Dystrophies, with positive commentary from analysts and investors.
- Analyst Coverage and Ratings: (35%) Stifel and H.C. Wainwright have reiterated positive ratings and price targets for Edgewise Therapeutics, citing positive data and potential.
- Mentions in Biotech Watchlists: (10%) Edgewise Therapeutics is included in biotech stock catalyst watchlists, indicating upcoming data readouts and potential catalysts.
Most Critical Themes
- Market Volatility: (10%) The stock price has shown volatility, with recent fluctuations and a significant drop from its 1-year high.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XX | X% | XXX | XX% | X | X% |
| Total | XX | X% | XXX | XX% | X | X% |
Social Dominance: XXXXXXX% #
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXXX% +0.001%
1 Month: XXXXXXX% +0.00175%
6 Months: XXXXXXX% -XXXXX%
1 Year: XXXXXXX% -XXXXX%
1-Year High: XXXXX% on 2024-12-04
1-Year Low: XXXXXX% on 2025-09-15
Market Dominance: XXXXXXX% #
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXX% on 2025-03-31
1-Year Low: XXXXXXX% on 2025-08-08
Market Cap: $XXXXXXXXXXXXX #
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX -$2.90%
1 Month: $XXXXXXXXXXXXX +$3.20%
6 Months: $XXXXXXXXXXXXX +$9.50%
1 Year: $XXXXXXXXXXXXX -$48%
1-Year High: $XXXXXXXXXXXXX on 2024-11-06
1-Year Low: $XXXXXXXXXXXXX on 2025-04-11
Top assets mentioned In the posts about Edgewise Therapeutics, Inc. Common Stock in the last XX hours
Cytokinetics Inc. (CYTK) Bristol-Myers Squibb Co (BMY) Dyne Therapeutics, Inc. Common Stock (DYN) Dyne Therapeutics, Inc. Common Stock (DYN) Corcept Therapeutics Inc. (CORT) Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Incyte Corporation (INCY) Summit Therapeutics Inc. Common Stock (SMMT) Revolution Medicines, Inc. Common Stock (RVMD)
Top topics mentioned In the posts about Edgewise Therapeutics, Inc. Common Stock in the last XX hours
stocks healthcare, $cytk, $bmy, $barcl, dyne therapeutics, $dyn, stocks consumer cyclical, stocks, $cort, $rytm, $incy, $smmt, $rvmd, $drug, $cve, $pvh, superior, united states, $knsa, $dnli, $twst, $agio, $cgon, $nvs, $wve, $rnac, $roiv, $glpg, $lxrx, $tnya, $imvt, hooked protocol, coins bsc, coins ai, coins gaming, $1b, stocks bitcoin miners, $alhc, $onc, $acad, $mdgl, $crnx, 24h, $mfh, $mobbw, $qmmm, $58k, $insm, $spx, $spy, $xbi, $qqq, discord, $prso, $tbio, $zeo, $lfly, $ptct
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"We gave it early. Discord: $PRSO $TBIO $ZEO $LFLY $FRGT $MAXN $TBIO $VMAR $VERI $ZEO $XCUR $GLMD $ACHL $EWTX $AMZN $GOOGL $TSLA $AMD $MSFT $NFLX $META $MSTR $NVDA $FSLR $FFIE $AAPL $QQQ $SPY $VIX $PRSO $AAPL $FSLR $MULN $BATL $BNZI $LFLY $SVMH $TNON $AENT"
X Link @stocket_rocket 2025-10-13T19:55Z XX followers, XX engagements
"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (2/3). $IMVT Phase X $HOOK Phase X $GNLX Phase X $GNLX Phase X $GLPG Phase X $EXEL Phase X $EXEL Phase X $EWTX Phase X $COYA Phase X $COGT Phase X $COGT Phase X $CGON Phase X $RNAC Phase X $BBIO Phase X $BMEA Phase X $BINV Phase 2a $BHVN Phase X $BHVN Phase X $ARGX Phase X $AMGN Phase X $ANRO Phase X $ANRO Phase 2b $ALKS Phase X $ELDN Phase X $ACLX Phase X $BIVI Phase 2b $KPTI Phase X $CRVS Phase X $ZVSA Phase 2a $ZBIO Phase X $VTGN Phase X $VTYX Phase X $VTYX Phase X $TERN Phase X $TARA Phase X $PHVS Phase X $MLTX Phase X $MBRX"
X Link @BiopharmIQ 2025-10-12T20:36Z 27.3K followers, XXX engagements
"nHCM landscape (source: Barclays). $CYTK $LXRX $EWTX $TNYA $LXEO"
X Link @doepke_michel 2025-10-10T11:25Z 5561 followers, 2078 engagements
"#Trendingsector #ThinkSabio #Trendingstock $SPX $SPY $XBI $QQQ $IWM #Markets #StockMarket #Stocks #Trending #mag7 BIO CATALYSTS TODAY (Oct XX 2025) $DTIL: $XXXX XX Week High: XXXX Market Cap: $69.31M Live cash est: $39.27M PBGENE-DMD Duchenne muscular dystrophy (DMD Preclinical data results to be presented at the WMS on October XX 2025. $EWTX: $XXXXX XX Week High: XXXXX Market Cap: $1.69B Live cash est: $557.07M EDG-5506 - (LYNX) Duchenne Muscular Dystrophy (DMD) Phase X data to be presented at the World Muscle Society (WMS) October XX 2025 Sevasemten (EDG-5506) - (CANYON) Becker Muscular"
X Link @thinksabio 2025-10-10T10:50Z XXX followers, XX engagements